Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin

Prostaglandins and Other Lipid Mediators

Volumn 70, Issue 1-2, 2002, Pages 209-226

  Fallani, Anna ^a   Grieco, Barbara ^a   Barletta, Emanuela ^a   Mugnai, Gabriele ^a   Giorgi, Gianluca ^b   Salvini, Laura ^b   Ruggieri, Salvatore ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Cytokines; Gas chromatography mass spectrometry negative ion chemical ionization; Metastasis; PAF; Tumor cell lines

Indexed keywords

ACETIC ACID; CALCIMYCIN; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL TRANSFORMATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROSARCOMA; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; IONIZATION; MACROPHAGE; MASS SPECTROMETRY; MELANOMA CELL; METASTASIS; NONHUMAN; QUANTITATIVE ANALYSIS;

3T3 CELLS; ACETIC ACID; ANIMALS; CELL LINE, TRANSFORMED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, INTERFERON; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036744079     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00109-0     Document Type: Article

References (59)

1. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am. J. Physiol. 259:1990;c697-c708.
2. Chignard M., Le Couedic J.P., Tence M., Vargftig B.B., Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature. 279:1979;799-800.
3. O'Flaherty J.T., Miller C.H., Lewis J.C., Wykle R.L., Bass D.A., McCall C.E.et al. Neutrophil responses to platelet-activating factor. Inflammation. 5:1981;193-201.
4. Prpic V., Uhing R.J., Weiel J.E., Jakoi L., Gawdi G., Herman B.et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. J. Cell Biol. 107:1988;363-372.
5. Bussolino F., Camussi G., Aglietta M., Braquet P., Bosia A., Pescarmona G.et al. Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeletal structure. J. Immunol. 139:1987;2439-2446.
6. Camussi G., Montrucchio G., Lupia E., De Martino A., Perona L., Arese M.et al. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol. 154:1995;6492-6501.
7. Montrucchio G., Lupia E., Battaglia E., Del Sorbo L., Boccellino M., Biancone L.et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler. Thromb. Vasc. Biol. 20:2000;80-88.
8. 4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl. Acad. Sci. USA. 83:1986;2204-2208.
9. Jackson R.J., Bolognese B., Mangar C.A., Hubbard W.C., Marshall L.A., Winkler J.D. The role of platelet-activating factor and other lipid mediators in inflammatory angiogenesis. Biochim. Biophys. Acta. 1392:1998;145-152.
10. Bazan H.E.P., Tao Y., Bazan N.G. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc. Natl. Acad. Sci. USA. 90:1993;8678-8682.
11. Camussi G., Aglietta M., Coda R., Bussolino F., Pacibello W., Tetta C. Release of platelet-activating factor (PAF) and istamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology. 42:1981;191-199.
12. Camussi G., Bussolino F., Salvidio G., Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J. Exp. Med. 166:1987;1390-1404.
13. Mencia-Huerta J.M., Benveniste J. Platelet-activating factor and macrophage. 1. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur. J. Immunol. 9:1979;409-415.
14. McIntyre T.M., Zimmerman G.A., Satoh K., Prescott S.M. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate. J. Clin. Invest. 76:1985;271-280.
15. Kester M., Nowinski R.J., Holthofer H., Marsden P., Dunn M.J. Characterization of platelet-activating factor synthesis in glomerular endothelial cell lines. Kidney Int. 46:1994;1404-1412.
16. Foa R., Bussolino F., Ferrando M.L., Guarini A., Tetta C., Mazzone R.et al. Release of platelet-activating factor in human leukemia. Cancer Res. 45:1985;4483-4485.
17. Bussolino F., Arese M., Montrucchio G., Barra L., Primo L., Benelli R.et al. Platelet-activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96:1995;940-952.
18. Sobhani I., Denizot Y., Moizo L., Laigneau J.P., Bado A., Laboisse C.et al. Regulation of platelet activating factor production in gastric epithelial cells. Eur. J. Clin. Inv. 26:1996;53-58.
19. Maggi M., Bonaccorsi L., Finetti G., Carloni V., Muratori M., Laffi G.et al. Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. Cancer Res. 54:1994;4777-4784.
20. Bussolati B., Biancone L., Russo S., Rola-Pleszczynsky M., Montrucchio G., Camussi G.et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am. J. Pathol. 157:2000;1713-1725.
21. Di Renzo M.F., Bretti S. Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts. Int. J. Cancer. 30:1982;751-757.
22. Valone F.H., Epstein L.B. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-β, tumor necrosis factor or IFN-γ J. Immunol. 141:1988;3945-3950.
23. Montrucchio G., Lupia E., Battaglia E., Passerini G., Bussolino F., Emanuelli G.et al. Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180:1994;377-382.
24. Cecconi O., Calorini L., Mannini A., Mugnai M., Ruggieri S. Enhancement of lung-colonizing potential murine tumor cell lines co-cultivated with activated macrophages. Clin. Exp. Metastasis. 15:1997;94-101.
25. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys. 37:1959;911-917.
26. Bossant M.J., Ninio E., Delautier D., Benveniste J. Biossay of PAF-acether by rabbit platelet aggregation. Meth. Enzymol. 187:1990;125-130.
27. Triolo A., Bertini J., Mannucci C., Perico A., Pestellini V. Analysis of platelet-activating factor by gas chromatography-mass spectrometry: low-energy electron impact of the corresponding 3-acetyl-2-tert-butyldimethylsilyl derivative. J. Chromatogr. 568:1991;281-289.
28. Hube F., Birgel M., Lee Y.-M., Hauner H. Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 29:1999;672-678.
29. Nagao M., Nakajima Y., Kanehiro H., Hisanaga M., Aomatsu Y., Ko S.et al. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma. Hepatology. 32:2000;491-500.
30. Chau L.I., Peck K., Yen H.H., Wang J.Y. Agonist-induced down-regulation of platelet activating factor receptor gene expression in U937 cells. Biochem. J. 301:1994;911-916.
31. Zhuang L., Wang B., Shinder G.A., Shivji G.M., Mak T.W., Sauder D.N. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J. Immunol. 162:1999;1440-1447.
32. Wei Y.P., Kita M., Shinmura K., Yan X.Q., Fukuyama R., Fushiki S.et al. Expression of IFN-γ in cerebrovascular endothlial cells from aged mice. J. Interferon Cytokine Res. 20:2000;403-409.
33. Mannori G., Barletta E., Mugnai G., Ruggieri S. Interaction of tumor cells with endothelia: role of platelet-activating factor. Clin. Exp. Metastasis. 18:2000;1-8.
34. Okahara H., Yagita H., Miyake K., Okumura K. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor α enhancement of experimental metastasis. Cancer Res. 54:1994;3233-3236.
35. Lollini P.L., De Giovanni C., Nicoletti G., Bontadini A., Tazzari P.L., Landuzzi L.et al. Enhancement of experimental metastatic ability to tumor necrosis factor-alpha alone or in combination with interferon-gamma. Clin. Exp. Metastasis. 8:1990;215-224.
36. Welch D.R., Fabra A., Nakajima M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA. 87:1990;7678-7682.
37. Rosen E.M., Goldberg I.D., Liu D., Setter E., Donovan M.A., Bhargava M.et al. Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res. 51:1991;5315-5321.
38. Lauricella-Lefebvre M.A., Castronovo V., Sato H., Seiki M., French D.L., Merville M.P. Stimulation of 92-kDa type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis. 13:1993;289-300.
39. Dabbous M.K., North S.M., Haney L., Nicolson G.L. Effects of mast cells-macrophage interaction on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin. Exp. Metastasis. 13:1995;33-41.
40. Chen Y.Q., Duniec Z.M., Liu B., Hagmann W., Gao X., Shimoji K.et al. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 54:1994;1574-1579.
41. Honn K.V., Tang D.G., Gao X., Butovich I.A., Liu B., Timar J.et al. 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev. 13:1994;365-396.
42. Young M.R., Okada F., Tada M., Hosokawa M., Kobayashi H. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior. Invasion Metastasis. 11:1991;48-57.
43. Fulton A.M., Heppner G. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Cancer Res. 45:1985;4779-4784.
44. Hanna N., Burton R.C. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J. Immunol. 127:1981;1754-1758.
45. Gorelik E., Wiltrout R.H., Okumura K., Habu S., Herberman R. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int. J. Cancer. 30:1982;107-112.
46. Im S.Y., Ko H.M., Kim J.W., Lee H.K., Ha T.J., Lee H.B.et al. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56:1996;2662-2665.
47. Orosz P., Echtenacher B.E., Falk W., Ruschoff J., Weber D., Mannel D.N. Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 177:1993;1391-1398.
48. Ramani P., Balkwill F.R. Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon gamma. Int. J. Cancer. 40:1987;830-834.
49. Montrucchio G., Sapino A., Bussolati B., Ghisolfi G., Rizea-Savu S., Silvestro L.et al. Potential angiogenic role of platelet-activating factor in human breast cancer. Am. J. Pathol. 153:1998;1589-1596.
50. Biancone L., Cantaluppi V., Boccellino M., Bussolati B., Del Sorbo L., Conaldi P.G.et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am. J. Pathol. 155:1999;1731-1739.
51. Boccellino M.R., Biancone L., Cantaluppi V., Ye R.D., Camussi G. Effect of platelet-activating factor receptor expression on CHO cell motility. J. Cell. Physiol. 183:2000;254-264.
52. Friedberg SJ, Smaidek J, Anderson K. Surface membrane O-alkyl lipid concentration and metastasizing behavior in transplantable rat mammary carcinomas. 1986;46:845-9.
53. Fallani A., Mannori G., Ruggieri S. Composition of ether-linked sub-classes of glycerophospholipids in clones with a different metastatic potential isolated from a murine fibrosarcoma line (T3 cells). Int. J. Cancer. 62:1995;230-232.
54. Calorini L., Fallani A., Tombaccini D., Mugnai G., Ruggieri S. Lipid composition of cultured B16 melanoma cell variants with different lung-colonizing potential. Lipids. 22:1987;651-656.
55. Calorini L., Fallani A., Barletta E., Mugnai G., Di Renzo M.F., Comoglio P.et al. Lipid characteristics of RSV-transformed Balb/c3T3 cell lines with different spontaneous metastatic potentials. Lipids. 24:1989;685-690.
56. Mutoh H., Ishii S., Izumi T., Kato S., Shimizu T. Platelet-activating factor (PAF) positively regulates the expression of human PAF-receptor transcript 1 (leukocyte type) through NF-kappa B. Biochem. Biophys. Res. Commun. 205:1994;1137-1142.
57. Dupuis F., Levasseur S., Jean-Louis F., Dulery C., Praloran V., Denizot Y.et al. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. Biochim. Biophys. Acta. 1359:1997;241-249.
58. Merendino N., Dwinell M.B., Varki N., Eckmann L., Kagnoff M.F. Human intestinal epithelial cells express receptors for platelet-activating factor. Am. J. Physiol. 277:1999;810-818.
59. Heller R., Bussolino F., Ghigo D., Garbarino G., Pescarmona G., Till U.et al. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J. Immunol. 149:1992;3682-3688.